This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In 2023 compared with 2022, the total volume of positron emission tomography (PET) scans increased 10.2% year over year, according to the newly published IMV 2024 PET Market Summary Report. In 2023, the average number of PETscans per fixed PET site (versus mobile PET) increased 6.7%
Alzheimer’s disease patients with cognitive impairment or dementia who were referred for amyloid PETscans had fewer hospitalizations compared with a matched control group, according to a study published October 9 in JAMA Neurology. Each participant was matched to a control Medicare beneficiary who had not undergone amyloid PET.
F-18 fluoroestradiol (FES)-PETscans can predict whether or not endocrine therapy may be effective in women with estrogen receptor (ER)-positive breast cancer, according to a study published March 13 in the Journal of Nuclear Medicine. A visual abstract of the analysis. A visual abstract of the analysis.
Thus, the researchers aimed to determine prospectively whether 18F-FES PET improves staging for patients with clinical stage II/III or local-regional recurrent, grade 1 or 2, ER-positive breast cancer compared with standard F-18 FDG-PET. The tumor in the right breast (T4N0M0, grade 3 ductal carcinoma) is visible on both PETscans.
That’s according to new PET imaging that shows the presence of activated T cells in the brain, spinal cord, gut and lung tissues of individuals who have recovered from COVID.
F-18 florbetaben PETscans for diagnosing Alzheimer’s disease can be reduced from 20 minutes to five minutes without losing accuracy, according to a recent study. Our findings suggest that shorter scan times are a viable and effective option for brain amyloid PET imaging in clinical settings,” the group wrote.
The research included 62 cognitively healthy individuals (average age, 50) who underwent a brain PETscan, body MRI, and metabolic assessment. They conducted a study that investigated any links between "modifiable lifestyle-related factors" such as obesity, body fat distribution and metabolic aspects, and Alzheimer's disease.
A PET study by researchers at the National Institutes of Health (NIH) has called into question the theory that ultraprocessed foods elicit brain responses akin to addictive drugs. Participants fasted for 12 hours before the first scan. Participants completed a five-day inpatient stay during which their diets were stabilized.
“With further tuning and validation, this pipeline may potentially add value in cancer screening, staging, diagnosis and prognosis," experts wrote in Cell Reports Medicine.
The agency is looking to lift the longstanding NCD that restricts patients to one amyloid-detecting positron emission tomography exam in their lifetime.
The algorithm allows for faster PETscanning, up to 75% faster without compromising image quality, according to the company. Telix’s leading PSMA-PET imaging kit, Illucix, is used to perform gallium-68 PSMA-11 imaging exams in men with prostate cancer.
Read more on AuntMinnie.com Related Reading: FDA grants full approval to Alzheimer's disease drug Leqembi CMS rethinks limit on PETscans for Alzheimer’s disease patients FDA doubles MRI scans needed for Aduhelm patients CMS to limit coverage of new drugs for Alzheimer's disease CMS scrubs rule restricting PET tracer coverage
Providers have reported issues with one Medicare Administrative Contractor covering PETscans, for example, with reimbursement falling significantly below the expense.
A group in France has offered an explanation for long COVID brain fog, with the concept based on a visual brain pattern they discovered on patient PETscans, according to a study published October 13 in Medical Hypotheses. “We A) PETscan of a healthy subject. (B) B) PETscan of a long COVID patient.
National Institutes of Health (NIH) has highlighted a study that shows cardiac PETscans can help identify people at risk for Parkinson’s disease and Lewy body dementia. Heart and brain PETscans from a study participant who developed Parkinson’s disease support a “body first” progression.
Chinese clinicians have provided evidence in a “real-world study” that shows amyloid PET imaging is effective for diagnosing and managing patients with Alzheimer’s disease, according to a study published February 8 in Alzheimer’s and Dementia. The clinical utility of amyloid PETscans has been systematically studied in many other countries.
The new radiotracer, called FDT, enables PETscans to be used for the first time to accurately pinpoint when and where the disease is still active in a patient's lungs. The team has developed a new radiotracer, which is taken up by live TB bacteria in the body.
PETScanning, like all other modalities of imaging equipment, has made strides in improving diagnostic accuracy. The biggest step in that direction for PET has been the development and proliferation of Time-of-Flight technology.
Centers for Medicare and Medicaid Services (CMS) announced on October 13 that it has lifted its coverage limit of one beta-amyloid PETscan per lifetime for patients with Alzheimer’s disease. Medicare coverage decisions for amyloid PETscans will now be made by local Medicare Administrative Contractors (MACs).
The researchers performed F-18 PBR06 PETscans on 22 patients with MS and eight healthy controls. According to the analysis, glial activity on F-18 PBR06 PETscans was higher in patients with MS than healthy controls in cortical gray matter (+33%) and white matter (+48%). Image courtesy of Clinical Nuclear Medicine.
All subjects underwent 90 minute dynamic whole-body PETscans using a dedicated research scanner called PennPET Explorer. Prior to PETscanning, subjects also underwent T1-weighted MRI brain imaging to create templates to segment the PET brain data into 10 regions of interest.
CT Scans: Provides cross-sectional images of the body for a more detailed view. PETScans : Help detect diseases at a cellular level, often used for cancer detection and brain disorders. Ultrasound : Uses sound waves to create images, often used during pregnancy or to check organs. How Does Early Detection Help?
Two experts review SNMMI (Society of Nuclear Medicine and Molecular Imaging) guidelines for use of PSMA PETscans in prostate cancer detection, as well as awareness about this new modality within the patient community.
The newly published study involved performing PETscans on 22 people with MS and eight healthy controls. Researchers measured the glial activity load on the PETscans, a new measure developed in Singhal’s lab where lab members looked at the level of smoldering inflammation from microglia in MS patients.
Florida resident Rick Nassenstein allegedly “played a central role” in a scheme that involved paying physicians “exorbitant” fees to refer patients for PETscans.
PETscans have revealed specific brain pathology that may drive sleep disturbances in Alzheimer’s disease patients, according to a study published February 8 in the Journal of the Neurological Sciences. Nonetheless, the results have several implications for clinical practice, they wrote.
The accumulation of brain amyloid deposits is a mechanism underlying Alzheimers disease, with amyloid PETscans used to diagnose the disease. To address the knowledge gap, the group identified 182 out of 1,680 participants in an Alzheimers disease study in France and Monaco who had both PETscans and HSV-1 blood tests available.
Early brain accumulation of amyloid plaque on PETscans is associated with emerging depressive symptoms in cognitively unimpaired older adults, according to a study published August 29 in JAMA Network Open. The mean follow-up period was 8.6
In a small study, researchers at the National Institutes of Health have found that positron emission tomography (PET) scans of the heart may identify people who will go on to develop Parkinson's disease or Lewy body dementia among those at-risk for these diseases.
A group in England has established PET imaging as a new approach for studying gait – an excellent indicator of physical, emotional, and mental health, according to a study published February 6 in NeuroImage. F-18 FDG-PETscans allow clinicians to measure the brain's energy demands based on glucose metabolism.
Patients with less tau pathology on PETscans may respond better to treatment with the new Alzheimer’s disease drug donanemab, according to an October 25 news report in the journal Practical Neurology. Research suggests that the accumulation of these proteins is a continuous process that starts decades before the onset of symptoms.
According to clinical trials, amyloid PETscans showed that donanemab reduced amyloid plaques by up to 84% after 18 months of treatment. Donanemab is a monoclonal antibody that targets and clears beta-amyloid protein in the brain.
The group analyzed flortaucipir (Tauvid, Avid Pharmaceuticals) PETscans acquired over a 3.5-year The researchers aimed to investigate whether menopausal HT use is associated with later-life tau accumulation. year period from 73 women who had used HT an average 14 years prior and 73 age-matched women who had not used HT.
F-18 FDG-PET is an established approach for diagnosing inflammation based on its ability to visualize increased cellular glucose metabolism, and the researchers hypothesized that it could be useful in patients with neurosarcoidosis. In all three cases, gadolinium-enhanced MRI scans did not show abnormalities.
A deep-learning AI model shows promise in helping clinicians assess cardiac sarcoidosis on PETscans, according to research presented on September 6 at the American Society of Nuclear Cardiology annual meeting in Austin, TX. The technique identifies areas of inflammation caused by the growth of tiny collections of inflammatory cells.
Both amyloid plaque brain deposits and changes in cerebral blood flow (CBF) are key components of Alzheimer’s disease, with amyloid PETscans and MRI typically used separately to detect changes in these biomarkers in patients.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content